EMERGENCY:Suspected organophosphate poisoning with pinpoint pupils, salivation, muscle twitching —call040-46324365immediately — 24 hours, 7 days— 24/7
Toxic-Metabolic Encephalopathy — Specialist Neurological and Toxicology Care in Hyderabad at KIMS
Toxic-metabolic encephalopathy is brain dysfunction — ranging from mild confusion to deep coma — arising from two categories of cause: direct exogenous toxins, and systemic metabolic disturbances from organ failure or systemic illness. The exogenous group covers a wide range of causative agents: agricultural pesticides (particularly organophosphates in Telangana and Andhra Pradesh), heavy metals (lead, mercury, manganese, arsenic, thallium), industrial solvents and chemicals, medications in overdose or at toxic levels, and recreational substances. The clinical presentation is often undifferentiated — a confused or unconscious patient — and the specific toxin must be identified through history, exposure context, and targeted blood and urine testing.
Toxic-metabolic encephalopathy is brain dysfunction (from mild confusion to deep coma) arising from two categories of cause: (A) direct exogenous toxins — drugs prescribed or recreational, alcohol, heavy metals, and industrial chemicals that affect brain function directly; and (B) systemic metabolic or toxic disturbance from organ failure or systemic illness — hepatic failure (hepatic encephalopathy), renal failure (uraemic encephalopathy), sepsis (septic encephalopathy), electrolyte and glucose disturbances, thyroid emergencies (myxoedema coma, thyroid storm), and nutritional deficiency such as thiamine deficiency (Wernicke's). Both categories produce diffuse cerebral dysfunction with a common presentation of altered consciousness, cognitive impairment, and behavioural change, which is why the workup screens for both. In India, the most important acute exogenous toxic encephalopathies are: (1) Organophosphate (OP) pesticide poisoning (chlorpyrifos, malathion, monocrotophos; extremely common in Telangana/AP agriculture); (2) Heavy metal poisoning (lead, mercury, manganese, arsenic — including from Rasa shastra Ayurvedic preparations); (3) Medication toxicity (lithium, methotrexate, cyclosporin/tacrolimus causing PRES); (4) Carbon monoxide (generators in enclosed spaces). OP poisoning produces three distinct temporal syndromes: acute cholinergic crisis (0–24 hours, SLUDGE + nicotinic + CNS), intermediate syndrome (24–96 hours, respiratory failure risk from proximal/respiratory muscle weakness, pralidoxime ineffective), and OP-induced delayed polyneuropathy (OPIDP, weeks, axonal neuropathy). Pralidoxime reactivates acetylcholinesterase but must be given before "aging" (irreversible OP-AChE bond forms within 24–48 hours). Atropine is titrated to drying of secretions, not to pupil size. The brain dysfunction is potentially reversible in most cases if the toxin is removed and the patient supported through the acute phase.
- Toxic-metabolic encephalopathy — the broader clinical term
- The syndrome covers two categories: direct exogenous toxins (alcohol, drugs, heavy metals, industrial chemicals, organophosphates) and systemic metabolic or toxic disturbance from organ failure or systemic illness (hepatic failure, renal failure, sepsis, electrolyte and glucose disturbance, thyroid emergencies, thiamine deficiency). Both present as diffuse cerebral dysfunction, so the workup screens for both rather than stopping at a toxin history.
- Three OP syndromes — timing determines treatment
- (1) ACUTE CHOLINERGIC CRISIS (0–24 hours): SLUDGE (Salivation, Lacrimation, Urination, Defecation, GI cramps, Emesis) + bronchospasm/bronchorrhoea + bradycardia + miosis + muscle fasciculations + seizures + altered consciousness. Treatment: atropine + pralidoxime urgently. (2) INTERMEDIATE SYNDROME (24–96 hours): after apparent recovery from acute crisis, proximal limb weakness + respiratory muscle weakness + cranial nerve palsies develop. Respiratory failure risk even in a seemingly recovering patient. PRALIDOXIME IS INEFFECTIVE at this stage. Ventilatory support may be needed. (3) OPIDP (weeks after exposure): axonal sensorimotor polyneuropathy from NTE inhibition. No specific treatment. Gradual recovery.
- Pralidoxime timing — aging is the race
- Pralidoxime (2-PAM) reactivates AChE by removing the OP molecule from the enzyme active site. But "aging" occurs: the OP-AChE bond becomes irreversible within 24–48 hours (faster with some OP agents like soman: within minutes to hours). After aging, pralidoxime is useless. Pralidoxime must be given as early as possible: loading dose 1–2 g IV over 15–30 minutes, then 500 mg/hour infusion. At KIMS, pralidoxime is stocked in the ED and ICU for immediate use.
- Atropine — titrated to secretions, NOT to pupils
- The correct atropine titration target in OP poisoning is DRYING OF SECRETIONS (reduction of bronchorrhoea, salivation, and lacrimation) — NOT achieving a specific heart rate or pupil size. Atropine does not reverse the nicotinic effects (muscle weakness, paralysis) and does not cross-react with pupil dilation reliably in OP poisoning. Doses may be large (2–20 mg or more in severe cases). Atropinisation endpoint = dry airway secretions.
- Manganism — the occupational basal ganglia toxin
- Manganism from occupational manganese exposure (welders, miners, battery workers): rigidity (more prominent than tremor, unlike PD), dystonia, cock-walk gait (high-stepping, walking on toes), emotional lability (manganese madness), L-DOPA UNRESPONSIVE (unlike PD), no significant rest tremor. MRI brain: symmetric T1 HYPERINTENSITY in the bilateral globus pallidus (from manganese deposition — manganese is paramagnetic). Differentiated from PD: MRI, L-dopa response, occupational history. No effective chelation — remove from exposure.
- Rasa shastra — the underreported India source
- Rasa shastra is the traditional Ayurvedic system of processing and using metals and minerals medicinally. The preparations (bhasmas) can contain lead, mercury, and arsenic. These preparations are widely used in India and are often not volunteered as "medications" when patients are asked about drug history. A direct, non-judgmental inquiry specifically asking about Ayurvedic, Siddha, Unani, homeopathic, and herbal preparations is essential in any patient with unexplained encephalopathy or peripheral neuropathy.
- Lead in children — no safe level
- Blood lead level: there is no safe level in children. Sub-clinical toxicity at low levels (ADHD-like behaviour, IQ reduction, hearing impairment) occurs well below the threshold for obvious encephalopathy. India-specific sources: old paint, battery recycling workshops near homes, Rasa shastra preparations, contaminated water. Chelation: DMSA for BLL >45 μg/dL in children. The most important step before chelation: remove the source (chelation cannot compete with ongoing exposure).
- PRES cross-reference
- PRES (Posterior Reversible Encephalopathy Syndrome) from calcineurin inhibitors (cyclosporin, tacrolimus in transplant patients) is a specific medication-induced toxic encephalopathy covered in detail in the Vascular Neurological Complications cluster. Key points: PRES can occur at therapeutic drug levels (not only in overdose); levetiracetam preferred over phenytoin in transplant patients; MRI T2/FLAIR bilateral posterior hyperintensity; reversible with BP control and drug dose reduction.
| Fact | Details |
|---|---|
| Definition — both categories | Direct exogenous toxins (alcohol, drugs, heavy metals, industrial chemicals, organophosphates) AND systemic metabolic/toxic disturbance from organ failure (hepatic, uraemic, septic, electrolyte and glucose disturbance, thyroid emergencies, thiamine deficiency) · Both produce diffuse cerebral dysfunction with a common clinical picture |
| OP poisoning: 3 syndromes | (1) Acute cholinergic crisis 0–24h: SLUDGE + nicotinic + CNS · (2) Intermediate syndrome 24–96h: proximal weakness + respiratory failure, pralidoxime ineffective · (3) OPIDP weeks: axonal neuropathy |
| Antidote timing | Atropine + pralidoxime immediately · Pralidoxime must be given BEFORE aging (24–48h) · Atropine titrated to secretion drying (NOT pupils or HR) |
| India-specific | OP: chlorpyrifos, malathion, monocrotophos in Telangana/AP agriculture · Rasa shastra bhasmas: lead, mercury, arsenic · Generator CO in enclosed spaces |
| Manganism | T1 hyperintensity bilateral globus pallidus · Rigidity > tremor · L-dopa unresponsive · Cock-walk gait · Welders, miners, battery workers · Remove from exposure |
| Lead (children) | No safe level · DMSA chelation for BLL >45 μg/dL · Remove source first · Sources: old paint, battery recycling, Rasa shastra, contaminated water |
| Mercury | Organic (methylmercury): cerebellar ataxia + visual field constriction (Minamata) · Chelation: DMSA or DMPS |
| PRES (medication) | Calcineurin inhibitors at therapeutic levels · See Cluster 15 for full PRES content · Levetiracetam over phenytoin in transplant patients |
About This Condition
Toxic-Metabolic Encephalopathy at a Glance
The essential facts that shape how toxic encephalopathy is recognised and managed at KIMS
Two categories of cause
Category 1 — direct exogenous toxins: alcohol (intoxication, Wernicke's, withdrawal) · drugs (opioids, benzodiazepines, anticholinergics, sedative-hypnotics) · heavy metals (lead, mercury, arsenic, thallium) · industrial chemicals and organophosphates. Category 2 — systemic metabolic or toxic disturbance from organ failure: hepatic failure (hepatic encephalopathy) · renal failure (uraemic encephalopathy) · septic encephalopathy · electrolyte disturbance (hyponatraemia, hypernatraemia) and hypo/hyperglycaemia · thyroid emergencies (myxoedema coma, thyroid storm) · thiamine deficiency (Wernicke's).
Organophosphates
Most common acute toxic encephalopathy in Telangana/AP · Acetylcholinesterase inhibition · SLUDGE + muscle fasciculations · Antidote: atropine + pralidoxime.
Heavy metals — lead
Plumbism: acute encephalopathy (children) or peripheral neuropathy (adults) · Blood lead level >45 μg/dL in children: chelation (DMSA, EDTA) · Sources: old paint, battery recycling, contaminated water.
Heavy metals — mercury
Organic (methylmercury): cerebellar ataxia + visual constriction (Minamata disease) · Inorganic: tremor + gingivitis + neuropsychiatric · Chelation with DMSA or DMPS.
Heavy metals — manganese
Manganism: parkinsonism + cock-walk gait + psychiatric · Occupational exposure (mining, welding, battery industry) · MRI: T1 hyperintensity in basal ganglia.
Solvents
Toluene (glue-sniffing): cerebellar ataxia + MRI periventricular changes · Carbon disulphide: encephalopathy + peripheral neuropathy · n-hexane: peripheral neuropathy.
Medications
Lithium toxicity: tremor + ataxia + encephalopathy · Methotrexate: leukoencephalopathy · Cyclosporin: PRES (posterior reversible encephalopathy syndrome) · Tacrolimus: PRES.
Alcohol
Acute intoxication + Wernicke (thiamine-dependent) + Korsakoff · See dedicated Wernicke-Korsakoff page.
India note
Organophosphate poisoning: major agricultural problem in AP/Telangana · Lead poisoning: battery recycling and Ayurvedic heavy metal preparations (Rasa shastra).
Toxic-Metabolic Encephalopathy — Brain Dysfunction from Exogenous Toxins
Toxic-metabolic encephalopathy is brain dysfunction — ranging from mild confusion to deep coma — arising from two categories of cause. The first is direct exogenous toxins: agricultural pesticides (particularly organophosphates in Telangana and Andhra Pradesh), heavy metals (lead, mercury, manganese, arsenic, thallium), industrial solvents and chemicals, medications in overdose or at toxic levels, alcohol, and recreational substances. The second is systemic metabolic or toxic disturbance from organ failure or systemic illness: hepatic failure (hepatic encephalopathy), renal failure (uraemic encephalopathy), sepsis (septic encephalopathy), electrolyte and glucose disturbances, thyroid emergencies, and nutritional deficiency such as thiamine deficiency (Wernicke's). Both categories produce diffuse cerebral dysfunction with a common clinical presentation of altered consciousness, cognitive impairment, and behavioural change. The clinical presentation is often undifferentiated — a confused or unconscious patient — and the specific toxin must be identified through history, exposure context, and targeted blood and urine testing.
The most important principle in toxic encephalopathy is that the brain dysfunction is, in most cases, potentially reversible if the toxin is removed and the patient is supported through the acute phase. The degree of reversibility depends on the toxin (some cause permanent neurological damage even after removal), the duration of exposure, and the severity of the acute injury. Early recognition and specific antidote therapy (where available) can be life-saving.
Emergency / Consultation
Speak directly with the KIMS neurotoxicology team — all coordinated under one roof. Available 24 hours for acute toxicological emergencies.
040-44885000Emergency line available 24 hoursOrganophosphate Toxic Encephalopathy
Three foundational principles that shape how organophosphate (OP) pesticide poisoning is recognised and treated at KIMS — the acetylcholinesterase inhibition mechanism that produces the SLUDGE syndrome and respiratory failure, the three distinct clinical syndromes that unfold from acute cholinergic crisis through the intermediate syndrome to OP-induced delayed polyneuropathy, and the time-critical role of pralidoxime before irreversible aging of the OP-AChE bond.
Mechanism — acetylcholinesterase inhibition and cholinergic excess
Organophosphate (OP) pesticides (chlorpyrifos, malathion, monocrotophos, quinalphos, phorate) inhibit acetylcholinesterase (AChE) — the enzyme that breaks down the neurotransmitter acetylcholine (ACh) at synapses. When AChE is inhibited, ACh accumulates at all cholinergic synapses: muscarinic synapses (producing the SLUDGE syndrome: Salivation, Lacrimation, Urination, Defaecation, GI cramps, Emesis) + Bronchospasm and bronchorrhoea + Bradycardia + Miosis (small pupils) + Nicotinic synapses (producing muscle fasciculations, weakness, and paralysis) + Central nervous system (producing seizures, loss of consciousness, central respiratory failure). Death from OP poisoning is primarily from respiratory failure (bronchospasm + secretions + diaphragm paralysis + central apnoea).
Three clinical syndromes of OP poisoning
(1) Acute cholinergic crisis (hours 0–24): the SLUDGE + nicotinic + CNS features described above. Treatment: atropine (titrated to drying of secretions, not to pupil size) + pralidoxime (2-PAM, within 24–48 hours to reactivate AChE before permanent "aging" occurs). (2) Intermediate syndrome (24–96 hours): after apparent recovery from acute crisis, proximal limb weakness + respiratory muscle weakness + cranial nerve palsies develop from persistent nicotinic receptor dysfunction. This can cause respiratory failure requiring ventilatory support even in a patient who seemed to be recovering. Pralidoxime is ineffective at this stage. (3) OP-induced delayed polyneuropathy (OPIDP, weeks after exposure): axonal sensorimotor peripheral neuropathy from NTE (neuropathy target esterase) inhibition. No specific treatment — gradual recovery.
Pralidoxime — the time-critical antidote
Pralidoxime (2-PAM) reactivates AChE by removing the OP molecule from the enzyme active site — but only if given before "aging" occurs. Aging is the irreversible bonding of the OP to AChE (typically within 24–48 hours, faster with some OPs like soman). After aging, pralidoxime is useless. Therefore, pralidoxime must be given as early as possible after OP poisoning — loading dose 1–2 g IV over 15–30 minutes, then infusion 500 mg/hour. At KIMS, pralidoxime is stocked in the emergency department and ICU for immediate use.
Heavy Metal Encephalopathy
Two of the most important heavy-metal neurotoxicology presentations seen at KIMS — childhood lead encephalopathy with its developmental neurotoxicity and chelation-responsive acute crisis, and the occupational parkinsonism of manganism that affects welders, miners, and battery workers and is recognisable by its characteristic MRI signature in the globus pallidus.
Lead encephalopathy — children are most vulnerable
Lead (plumbism) causes different neurological presentations by age: Children: acute encephalopathy (cerebral oedema, vomiting, ataxia, seizures, coma) at blood lead levels >70 μg/dL · Sub-acute cognitive impairment, ADHD-like behaviour, hearing loss, and IQ reduction at lower levels (no safe blood lead level exists). Adults: predominantly peripheral neuropathy (wrist drop from radial nerve involvement is classic) + cognitive impairment · Encephalopathy at very high levels. India-specific sources: old paint in heritage homes · Battery recycling workshops · Lead-containing Ayurvedic and Siddha preparations (Rasa shastra: bhasmas containing lead, mercury, arsenic) · Contaminated water from lead pipes. Blood lead level is the diagnostic test. Chelation therapy: DMSA (dimercaptosuccinic acid) for children with BLL >45 μg/dL · Ca-EDTA for very high levels or encephalopathy.
Manganism — the occupational basal ganglia toxin
Manganese causes a distinctive parkinsonian syndrome (manganism) from accumulation in the globus pallidus and substantia nigra. Features: rigidity (more prominent than tremor, unlike Parkinson's disease) · Dystonia · Cock-walk gait (high-stepping, walking on the toes) · Emotional lability and psychiatric features (manganese madness) · No tremor at rest (unlike PD) · L-dopa-unresponsive (unlike PD). MRI brain: symmetric T1 hyperintensity in the globus pallidus (due to manganese deposition). India: welders, miners (manganese ore), battery production workers, workers in the ferro-manganese industry. No effective chelation for manganism — prevention is the primary intervention. Remove from exposure.
Treatment
Medication-Induced Toxic Encephalopathy — PRES
Posterior Reversible Encephalopathy Syndrome is the archetypal medication-induced toxic encephalopathy at KIMS — common in post-transplant patients on calcineurin inhibitors, classically presenting with seizures, visual disturbance, and hypertension, and usually fully reversible with prompt blood-pressure control and drug-dose adjustment.
PRES — Posterior Reversible Encephalopathy Syndrome
PRES is a distinct MRI-defined toxic/hypertensive encephalopathy pattern: vasogenic oedema predominantly in the posterior parietal and occipital white matter, appearing as T2/FLAIR hyperintensity bilaterally. PRES is caused by failure of cerebrovascular autoregulation: hypertensive crisis · Cyclosporin or tacrolimus toxicity (very common in post-transplant patients) · Eclampsia · High-dose cytotoxic chemotherapy · IVIG. Clinical features: subacute headache · Seizures (often the presenting feature) · Visual disturbance (cortical blindness or visual field defects from occipital involvement) · Encephalopathy. PRES is usually reversible within days to 2 weeks of treating the cause: controlling blood pressure · Withdrawing the offending drug. MRI at KIMS confirms the diagnosis and excludes stroke.
Management at KIMS
The KIMS toxic encephalopathy programme integrates four interlocking acute-phase actions.
Acute Toxic Encephalopathy — General Principles
Remove the toxin: Gastric lavage if recent oral ingestion · Activated charcoal for relevant toxins · Skin decontamination for dermal exposure (OP) · Haemodialysis for dialysable toxins (lithium, methanol, ethylene glycol) · Chelation for metals.
Antidote if available: Atropine + pralidoxime (OP) · DMSA/Ca-EDTA (lead) · DMSA/DMPS (mercury) · Desferrioxamine (iron) · Naloxone (opioids) · Flumazenil (benzodiazepines, use cautiously) · 100% O₂ /HBO (CO).
Supportive care: Airway, breathing, circulation · Seizure management (benzodiazepines first-line) · Correct metabolic derangements.
Neurological monitoring: EEG for seizure detection · ICP monitoring if cerebral oedema · Ophthalmology for occupational metal exposures.
Related Conditions
Toxic encephalopathy belongs to the family of acquired brain injuries evaluated and managed at KIMS Neuroscience. Explore related acquired-brain-injury conditions.
FAQs
Frequently Asked Questions
A farmworker who cannot be woken. A child with lead in their blood from an unknown source. A welder who walks differently. A transplant patient who has had a seizure. Toxic encephalopathy has specific causes, specific antidotes, and specific treatments that make the difference between recovery and permanent neurological damage.
At KIMS Hyderabad, the neurotoxicology and neurointensive care teams respond to all toxic brain injury emergencies. Emergency: 040-46324365. Outpatient: 040-44885000.
International enquiries: info@kimsneurosciences.com